2005
DOI: 10.1016/s1569-9056(05)80214-3
|View full text |Cite
|
Sign up to set email alerts
|

206The novel oral protein prenyl transferase inhibitor AZD3409 inhibits prostate epithelial cell proliferation and invasion in vitro, without bone marrow toxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2005
2005
2008
2008

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…This inhibitory effect has been demonstrated in vitro in PCa using zoledronic acid [25] and the prenylation inhibitor AZD3409 [33,55]. The inhibitory effects of these compounds are known to be related to Rho through its interaction with Ras [56].…”
Section: Distal Attachment and Tumour Cell Transmigration Through Thementioning
confidence: 99%
“…This inhibitory effect has been demonstrated in vitro in PCa using zoledronic acid [25] and the prenylation inhibitor AZD3409 [33,55]. The inhibitory effects of these compounds are known to be related to Rho through its interaction with Ras [56].…”
Section: Distal Attachment and Tumour Cell Transmigration Through Thementioning
confidence: 99%
“…The effect of Ras-Rho inhibition of reducing the propensity of PECs to invade across endothelial barriers suggests that a major component affecting cancer cell migration is inhibition of transduction pathways related to the Rho axis. This inhibitory effect has been demonstrated in vitro in PCa using zoledronic acid [25] and the prenylation inhibitor AZD3409 [33,55]. The inhibitory effects of these compounds are known to be related to Rho through its interaction with Ras [56].…”
Section: Distal Attachment and Tumour Cell Transmigration Through The Endotheliummentioning
confidence: 99%